What is CARL's cash & equivalents?

CARL (CARL) reported cash & equivalents of $73.02M in Q1 2026.

How has CARL's cash & equivalents changed year-over-year?

CARL's cash & equivalents increased by 68.1% year-over-year, from $43.43M to $73.02M.

What is the long-term trend for CARL's cash & equivalents?

Over 2 years (2023 to 2025), CARL's cash & equivalents has grown at a 244.7% compound annual growth rate (CAGR), from $7.22M to $85.79M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

CARL CARL Cash & Equivalents

Cash & Equivalents at other companies

Johnson & JohnsonJNJ

$21.69B-43.6%

StrykerSYK

$2.88B+24.1%

Orthofix Medical Inc.OFIX

$120.28M+108%

Globus MedicalGMED

$560.95M+21.6%

Alphatec HoldingsATEC

$139.91M-8.7%

MedtronicMDT

$1.95B-12.1%

Other financials

Income statement

See full

Revenue$16.1M+58.2%

Gross profit$12.4M+62.7%

Operating income-$9.3M-62.2%

Net income-$8.7M-51.8%

EPS (diluted)-$0.32+78.2%

Balance sheet

See full

Total debt$17.3M—

Total equity$92.2M+220%

Total assets$118.8M—

Cash flow

See full

Operating cash flow-$13.0M-59.5%

CapEx$79.0K-4.8%

Free cash flow-$13.1M-58.8%

Valuation

See full

Market cap$305.56M-20.3%

Enterprise value$249.8M—

P/S5.4×—

Profitability

See full

Gross margin75.9%+1.4pp

Operating margin-60.5%-10.2pp

Net margin-57.8%-11.2pp

FCF margin-61.1%—

Returns & leverage

See full

Return on equity-416.9%—

Debt / equity0.2×—

Current ratio11.9×—

Where this comes from

Reported directly by CARL in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: CARL’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CARL's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CARL's cash & equivalents?: CARL (CARL) reported cash & equivalents of $73.02M in Q1 2026.
How has CARL's cash & equivalents changed year-over-year?: CARL's cash & equivalents increased by 68.1% year-over-year, from $43.43M to $73.02M.
What is the long-term trend for CARL's cash & equivalents?: Over 2 years (2023 to 2025), CARL's cash & equivalents has grown at a 244.7% compound annual growth rate (CAGR), from $7.22M to $85.79M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.